Introduction
============

B cells play an important role in the immune system due to production of the immunoglobulin and secreting several cytokines. B-cell population can be divided into several subsets like immature B cells, native B cells, memory B cells and plasma cells which all of them are important in immunological responses ([@B1]). B cells develop from hematopoietic stem cells (HSCs) in adult bone marrow (BM) by passing through lineage commitment and several stages before migration to secondary lymphoid tissues ([@B2]). It has been shown that CD10+ CD19+ B cells successfully are produced in the presence of stem cell factor (SCF) and Flt3 ligand (Flt3L) from human umbilical cord blood (CB) CD34+ cells within 4 weeks ([@B2]). Moreover, human hematopoietic stem cells don't require the direct interactions with stromal cells for B cell generation ([@B2]). IL-7 and Flt3L are known

to be essential for adult B lymphopoiesis in mice ([@B3],[@B5]). In contrast, in human, IL-7 is not required for B cell development ([@B6], [@B7]). However, it has been shown that SCF is important for B cells development ([@B8], [@B9]). In human, Flt3L is critical to cell survival and proliferation of HSPC as well as to B lymphopoiesis ([@B8], [@B9]). It is also reported that IL-7 induces little increase of human B production in co-cultures with stromal cells and B cell proliferate in IL7 independency ([@B6]). Moreover, In patients with lack of IL-7 receptor, B lymphopoiesis was normal while T and NK cells development were severely impaired ([@B6],[@B7]) .

IL2, IL7, and IL15 cytokines are referred to as the γc-common family ([@B10]). The γc protein belongs to hematopoietin receptor superfamily. They play an essential role in lymphopoiesis which its clearly demonstrated by human X-linked severe combined immunodeficiency ([@B11], [@B12]).

IL-2, IL-7, and IL-15 effect on either growth or differentiation of B cells. IL-7, is essential for T cell-independent growth of pre-B cells, while IL-2, and IL-15 influence T cell-dependent B cell proliferation and differentiation ([@B13]-[@B16]).

Common γ chain cytokines may support B cell proliferation activity synergistically or in an additive manner. Thus, the present study focused specifically on IL2, IL7, and IL15 cytokines that may play critical role in B cell proliferation in cord blood. It is known that IL-7 has a mutual role in B cell development and NK cells differentiation ([@B17], [@B18]). IL-2 as a T cell growth factor also mediates in activated B cell proliferation and NK cells differentiation ([@B19]-21). In cord blood, the B-cell population is enriched (around 11%) as compared to adult peripheral blood (about 5%) (22) . It has been shown that cord blood B cells are able to expressed complete high-affinity IL-2 receptor ([@B1]). Umbilical cord blood (UCB) is an alternative source of hematopoietic stem cells (HSCs) for transplantation. B cells are the most important preventive player in post transplantation bacterial infections. Therefore, it is very critical to understand how B cells could be enriched in transplanted cells.

In this study, the influence of IL2, IL7, and IL15 in the expansion of B cells in CD34+ fraction of cord blood mononuclear cells was evalueted. Furthermore, the most effective cytokine in B cell expansion in cord blood mononuclear cells is investigated.

Materials and Methods
=====================

***Cell isolation, Culture condition, and cytokines***

Experimental Ethical matters have been approved by Ethical committee of Tabriz medical university. Five cord blood samples were collected from full-term normal deliveries. All samples were diluted 2:1 with phosphate-buffered saline (PBS- SIGM). Then, mononuclear cells were isolated by centrifugation on Ficoll-paque (GE healthcare, 1.078 g/ml) at 850 gm for 25 minutes. The mononuclear cells were collected, washed twice in RPMI1640 (Gibco) and supplemented with 10% FBS (Gibco).

The 10^5^ cord blood mononuclear cells were seeded in 96-well plates in 250 µL of RPMI1640 (Gibco) including 20% fetal bovine serum (FBS; Gibco), and 1% penicillin/streptomycin (Gibco), then supplemented with cytokines including SCF , Flt3 ligand, interleukin 7, IL-15, and IL-2 . All cytokines purchased from PeproTech company (Germany) and used with a final concentration 40 ng/mL. Culture conditions designed in 6 groups including: 1.No cytokine, 2.SCF+Flt3 ligand, 3. SCF+FL+IL-2, 4. SCF+FL+IL-7, 5.SCF+FL+IL-15, and 6. SCF+FL+IL-2+IL-7+IL-15

Cells were incubated at 37°C for 21 days and half of the coculture medium (medium+ cytokines) was replaced at days 7, 14.

***Monoclonal antibodies and flow cytometry***

Monoclonal antibodies used in this study were CD34 (PerCP; clone 581; Abcam) and CD20 (PE; clone 2H7; BD Biosciences). Harvested cells evaluated by flow cytometry at days 0, 7, 14, and 21. We excluded dead cells using Propidium iodide (1.0 mg/mL; Invitrogen). FACS plots were saved by collecting between 10000 to 30000 events and using BD caliber (BD ebioscience). The obtained data were analysed by flowing software (Perttu Terho, version: 2.5.1.).

***Statistical analysis***

The analysis was performed by GraphPad Prism software (5.04). The statistical significances were determined using one-way ANOVA and Tukey\'s multiple comparison post-test. P \< 0.05 was considered statistically significant.

Results
=======

**Role** ***of cytokines in the generation of B cells from cord blood CD34positive and negative cells***

Harvested cord blood mononuclear cells evaluated by FACS at distinct time periods ([Figure1](#F1){ref-type="fig"}). We gated on CD34+ andCD34- cells to evaluate the percentage of derived CD20+ B cells. As shown in ([Figure1](#F1){ref-type="fig"}), CD34+ cells significantly produced CD20+ cells between 60 to 80 percent more than the CD34- fraction.

In presence of the combination of all cytokines, the percentage of B cells increased significantly from 21% at day 7 to 90% at day 14 ([Figure2](#F2){ref-type="fig"}). IL-7 in comparison with IL-2 and IL-15 produced higher B cells derived from CD34+ cells (90.65%) ([Figure2D](#F2){ref-type="fig"}). However, on day 21, in the presence of IL-2, the percentage of B cells derived from CD34+ fraction was approximately at same level as for IL-7 (85.7%). However, in presence of IL-2 and IL-15, the percentage of B cells derived from CD34+ cells were 87.8% and 64% respectfully on day 14 ([Figure2C, E](#F2){ref-type="fig"}). Moreover, in combination of all cytokines, the percentage of B cells was 83.3% ([Figure2F](#F2){ref-type="fig"}). There is significant difference between the expansion of CD20+CD34+ and CD20+CD34- in different time periods. In addition, the percentage of CD20+CD34- cells decreased on day21 ([Figure2](#F2){ref-type="fig"}).

***Mean fleurosence intensity (MFI) of CD20+ cells***

Mean fleurosence intensity (MFI) rate is a numerical data reflecting the severity of antigen expression (23). Mean fleurosence intensity of CD20+ cell evaluated by FACS on day 0, 7, 14, and 21 from cord blood CD34+ cells.

Our data showed the MFI of CD20+ cells increased from day 0 to day 21 when used SCF+FL +IL7 (P value \< 0.004) ([Figure3](#F3){ref-type="fig"}). However, MFI did not change in presence of IL2 and IL15. However, in IL-7 group, MFI increased slightly from day 7 to day 21 and in the last time point, it was higher in comparision to other cytokine combinations.

![Representative FACS profile of 10^5^ cultured cord blood mononuclear cells in identical time points.CD20^+^CD34^+^ (shown CD34+) and CD20^+^CD34^-^(shown CD34 -) evaluated by gating on lymphoid population in FSC versus SSC.](ijpho-5-155-g001){#F1}

![Percentage of CD20+CD34+ and CD20+CD34- cells derived from cord blood mononuclear cells. Flow cytometry and mean (SD) were used to evaluate the expression of CD20+ cells in different time points in the presence of different combination of cytokines: no cytokines (A), SCF+FL(B), SCF+FL+IL-2, P value \< 0.0002 (C), SCF+FL+IL-7, P value \< 0.0001 (D), SCF+FL+IL-15 (E) and SCF+FL+IL-2+IL-7+IL-15, P value \< 0.001(F). The percentage of CD20+CD34+ and CD20+CD34- Cells increased after 14 days of culture in the presence of cytokines. (+) CD34 postitive and (-) CD34 negative](ijpho-5-155-g002){#F2}

![Mean fleurosence intensity (MFI) of different cytokines are in same level. Mean fleurosence intensity of CD20+ cell evaluated by FACS in indicated time points from CD34+ cells derived cord blood mononuclear cells](ijpho-5-155-g003){#F3}

Discussion
==========

Previous studies have shown that IL2, IL7 and IL15 as a member of γ common chain superfamily have critical role in lymphopoiesis. The receptor for each γc-common cytokine may activate more than one intracellular signaling pathway (24, 25). Therefore, B cells proliferation can be affected by cytokines in synergistically or additive way. Several investigators clearly clarified that γc-common cytokines play a critical role in B cell proliferation. In addition, it has been shown that there is a relationship between IL-2 and IL-7 with B cell differentiation ([@B1], [@B17]). B cells derived from cord blood are very important during transplantation for leukemia. Donors are susceptible to infect bacteria and fungi due to suppression of immune system. Therefore, B cell development from cord blood transplanted cells could help donors to recover fast and reduce the relapse in case of bacterial infections. Thus, it is very important to understand whether B cell derived from cord blood cells affected by IL-2, IL-7, and IL-15. In this study, we evaluated the potential of UCB CD34+ cells to differentiate B cells. We cultured cord blood mononuclear cells in the presense of SCF, Flt3, IL-2, IL-7, and IL-15. The percentage of B cells derived from CD34+ and CD34- at different time points was investigated in the current study. Furthermore, the effects of IL-2, IL-7, and IL15 on B cell expansion from cord blood mononuclear cells were explored. The obtained results depicted that IL-7 and IL-2 influenced on B cell differentiation from CD34+ cord blood cells; neverthelse, the effect of IL7 was more than IL-2. As well as in the presence of IL7 the MFI was higher than IL2. In contrast, IL-15 didn't increase B cell differentiation significantly. Moreover, our data showed that day 14 is the latest time point to get more B cell expansion. This fast differentiation of B cells was only in cord blood cells because they were fast proliferative in comparison with bone marrow.

Conclusion
==========

Our data illustrated that IL2 and IL7 can be used in ex vivo expansion to get more B cells from cord blood cells. For further study, it is important primarily to understand the differences between B cell derived by IL2 and IL7and to evaluate the function of derived B cells.
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